Academy Exchange

 View Only

  • 1.  CMS requesting public comment on Apretude being covered under CMS rule for PrEP

    Posted 01-13-2023 10:35
    Edited by Eric Farmer 01-13-2023 11:32
    ViiV as officially requested their product, Apretude, be included for coverage of PrEP for individuals at high risk of HIV acquisition since PrEP carries a "Grade A" recommendation from the USPSTF. Public comment is requested for its consideration. CMS is particularly interested in comments that include scientific evidence. A link to the ViiV letter as well as a link to instructions on submitting comments can be found on the webpage. 

    NCA - Preexposure Prophylaxis (PrEP) Using Antiretroviral Therapy to Prevent Human Immunodeficiency Virus (HIV) Infection (CAG-00464N) - Tracking Sheet (cms.gov)


    ------------------------------
    Eric Farmer
    Indiana University Health
    IndianapolisIN
    ------------------------------


  • 2.  RE: CMS requesting public comment on Apretude being covered under CMS rule for PrEP

    Posted 02-01-2023 15:33
    Thank you so much for this information, Eric! My organization has submitted public comment.

    ------------------------------
    Kevin Aloysius
    HoustonTX
    ------------------------------

    Original Message